IG
UTHR icon

ING Group’s United Therapeutics UTHR Stock Holding History

ING Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
+18,800
New +$10.6M 0.05% 245
2024
Q2 		– Sell
-8,800
Closed -$2.02M – 629
2024
Q1 		$2.02M Buy
8,800
+1,800
+26% +$406K 0.01% 446
2023
Q4 		$1.54M Buy
+7,000
New +$1.61M 0.01% 435
2019
Q3 		– Sell
-6,715
Closed -$524K – 745
2019
Q2 		$524K Buy
+6,715
New +$628K 0.01% 501
2018
Q4 		– Sell
-6,660
Closed -$852K – 831
2018
Q3 		$852K Buy
+6,660
New +$824K 0.01% 399
2016
Q1 		– Sell
-3,345
Closed -$524K – 681
2015
Q4 		$524K Buy
+3,345
New +$487K ﹤0.01% 565
2014
Q2 		– Sell
-42,396
Closed -$3.99M – 690
2014
Q1 		$3.99M Sell
42,396
-2,124
-5% -$217K 0.02% 400
2013
Q4 		$5.03M Sell
44,520
-3,266
-7% -$295K 0.03% 362
2013
Q3 		$3.77M Hold
47,786
– – 0.02% 417
2013
Q2 		$3.14M Buy
+47,786
New +$3.08M 0.02% 425

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

ING Group's UTHR Position: Q2 2026 in Review

ING Group opened a new position in United Therapeutics (UTHR) in Q2 2026: 18,800 shares worth $10.2M. The stake represents 0.05% of the portfolio and ranks #245 among its holdings. This is a return to the name: ING Group previously reported a position in UTHR as recently as Q1 2024.

ING Group first reported a position in UTHR in Q2 2013 and has held it in 10 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • ING Group held 18,800 shares of United Therapeutics worth $10.2M as of Q2 2026.
  • United Therapeutics was a new ING Group position in Q2 2026.
  • United Therapeutics made up 0.05% of ING Group's portfolio in Q2 2026, its #245 holding.
  • ING Group first reported a position in United Therapeutics in Q2 2013 and has held it in 10 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.